Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Chronic skin disease lead to skin damage and disfiguring to the patient skin. Sometimes, achieving normal skin is not possible by the normal traditional treatment, this study is focusing on use of ACE CSD formula which is mixture of natural peptides and herbs. the main aim is to restore the normal skin appearance for the patient and control the episodes of flare.
Psoriasis is a chronic, immune mediated (type 2 and type 17) chronic skin disease. The production of the immune proteins that leads to continuous inflammatory mediated process. The result of chronic inflammation is they hyper keratotic layer of skin which gets attacks of atopic dermatitis leading to symptoms of itching, pruritis and in situ bleeding.
ACE CSD, with the multiple factors that mediates the immune response and control the protein receptors, in addition to the multiple regeneration peptides that are specifically extracted from healthy skin of newly born sheep; in addition to multiple Chinese herbs that contains different anabolic factors was tested to be able to regenerate the damaged skin and locally modulate the immunity reactions so the skin can regenerate fully to replace the damaged skin with normal healthy skin.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| internvention of Chrinic skin conditions | Experimental | All cases of chronic skin conditions will be included to measure the effect on the 3 of them and whihc one will respond to the treatment better |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ACE CSD | Combination Product | Topical application of the ACE CSD 4 times daily. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Regeneration of the damaged skin lesion | Complete regeneration of the affected skin lesions from the skin disease. | 6 - 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| Flare control | During the attacks of flare, the regenerated skin does not get affected nor show erythematous reaction | 1-3 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dr. Alaa Abdelkarim MF Mohammed | Contact | +447473922553 | dralaakarim@gmail.com | |
| Dr. Diana Diana, MsC Dermatology | Contact | dr.dianadiana@outlook.com |
| Name | Affiliation | Role |
|---|---|---|
| Dr. Diana Diana, MSc Dermatology | ACE cells Lab europe DOO | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ACE cells Lab Europe Doo | Belgrade | 11000 | Serbia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011565 | Psoriasis |
| D003876 | Dermatitis, Atopic |
| D004485 | Eczema |
| ID | Term |
|---|---|
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012873 | Skin Diseases, Genetic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ACE Cells Lab Limited | Nottingham | Nottinghamshire | NG90 6BH | United Kingdom |
|
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D003872 | Dermatitis |
| D017443 | Skin Diseases, Eczematous |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |